Abstract

Chronic diseases such as diabetes, hypertension, and cardiovascular diseases require long-term medication adherence to manage symptoms and prevent complications. However, medication non-adherence remains a significant barrier to effective disease management and optimal health outcomes. This non-adherence can result in increased hospitalizations, higher healthcare costs, and a greater burden on the healthcare system. This systematic review examines the role of community pharmacists in managing medication adherence among patients with chronic conditions such as Diabetes and hypertension. Medication adherence is critical for effective chronic disease management, and community pharmacists are strategically positioned to influence adherence behaviours positively. The findings of this review will inform healthcare policies and practices, emphasizing the importance of integrating community pharmacists into multidisciplinary care teams to improve chronic disease management. Evidence from numerous studies underscores the effectiveness of pharmacist-led interventions in improving clinical outcomes, reducing hospitalizations, and enhancing patient satisfaction and quality of life. However, the full potential of pharmacists in this role is yet to be realized due to barriers such as limited reimbursement, the need for additional training, and the necessity for better integration into healthcare teams. In conclusion, integrating community pharmacists more fully into healthcare teams represents a promising strategy for improving medication adherence and managing chronic diseases effectively. By leveraging their expertise and patient-centred approach, pharmacists can make substantial contributions to better health outcomes and a more efficient healthcare system.

Keywords

Introduction

Community pharmacists are healthcare professionals who provide medication counseling, conduct medication therapy management (MTM), and offer various patient care services. Their frequent interactions with patients place them in a unique position to support and monitor medication adherence. Chronic diseases such as diabetes, hypertension, and asthma require long-term medication adherence for effective management. Poor adherence to medication regimens can lead to worsening health outcomes, increased hospitalizations, and higher healthcare costs. Community pharmacists, due to their accessibility and frequent patient interactions, have the potential to play a significant role in improving medication adherence [1]. This review aims to systematically evaluate the impact of community pharmacists on medication adherence in patients with chronic conditions by synthesizing data from existing research studies.

METHODS

Search Strategy

A comprehensive literature search was conducted using databases such as PubMed, Cochrane Library, Embase, and Google Scholar. Keywords included "community pharmacist," "medication adherence," "chronic conditions," "medication therapy management," and "patient counseling." The search was limited to studies published in English from 2000 to 2018.

Study Selection

Studies were included if they met the following criteria:

• Focused on chronic conditions requiring long-term medication
• Involved community pharmacist-led interventions aimed at improving medication adherence
• Reported quantitative outcomes related to medication adherence

Data Extraction and Analysis

Data were extracted using a standardized form, including study characteristics, types of interventions, adherence measurement methods, and key findings. The data were synthesized to identify common themes and evaluate the overall effectiveness of the interventions.

The Importance of Medication Adherence

Chronic diseases, such as diabetes, hypertension, and cardiovascular diseases, are leading causes of morbidity and mortality globally. Effective management of these conditions largely depends on patients adhering to their prescribed medication regimens. Despite the availability of effective treatments, medication non-adherence remains a prevalent issue, compromising treatment outcomes and resulting in significant healthcare costs [2-4]. Medication adherence is essential for achieving optimal therapeutic outcomes in chronic disease management [5]. Adherence leads to better clinical outcomes, such as improved disease control and reduced complications, whereas non-adherence can result in disease progression, increased hospitalizations, and higher mortality rates [6]. Factors influencing adherence include:

Patient-related factors:

Forgetfulness, lack of understanding of the disease, and fear of side effects.

Therapy-related factors:

Complexity of medication regimens and adverse effects.

Healthcare system-related factors:

Poor patient-provider communication and inadequate follow-up [7-8].

The Role of Community Pharmacists

Community pharmacists play an integral role in enhancing medication adherence among patients with chronic conditions. Positioned as the most accessible healthcare professionals, pharmacists interact frequently with patients, offering a unique opportunity to provide consistent and personalized support [9-11]. This support begins with comprehensive medication therapy management (MTM), where pharmacists conduct thorough reviews of patients' medication regimens, identify potential barriers to adherence, and develop tailored strategies to overcome these obstacles [12]. For instance, they might simplify complex medication schedules, address side effects that deter adherence, or educate patients about the importance of their prescribed treatments. This patient-specific approach helps to demystify chronic conditions and their management, fostering a better understanding and encouraging patients to adhere to their medication regimens [13-15].

Medication Therapy Management (MTM)

MTM services involve comprehensive medication reviews, identifying and resolving medication-related problems, and optimizing medication regimens. Pharmacists can detect barriers to adherence and implement strategies to overcome them, such as simplifying medication schedules or managing side effects [16, 17]. Moreover, pharmacists play a crucial role in patient education and counseling, essential components in managing chronic diseases effectively. They provide detailed information about each medication, including its purpose, potential side effects, and the critical importance of taking it as prescribed [18]. Through effective communication, pharmacists build trust and rapport with patients, which is vital for encouraging adherence. They also use motivational interviewing techniques to understand patients' concerns and barriers, offering solutions and support to enhance their motivation to stick to their medication plans. This personalized engagement helps patients feel more supported and informed, significantly improving their likelihood of adhering to their treatment regimens [19, 20]. In addition to direct patient interaction, community pharmacists leverage various adherence support tools to aid patients in managing their medications effectively . These tools include pill organizers, medication synchronization programs, and digital reminders such as phone calls, text messages, and mobile apps. By incorporating these tools into their practice, pharmacists help patients stay organized and reduce the chances of missed doses. Medication synchronization programs, for instance, align refill dates for all of a patient's medications, minimizing the number of trips to the pharmacy and simplifying the process of taking multiple medications. Digital reminders serve as prompts to ensure patients take their medications on time, addressing forgetfulness, one of the most common barriers to adherence [21-23]. Furthermore, the role of community pharmacists extends into collaborative practice models, where they work closely with other healthcare providers to manage patients' chronic conditions comprehensively [24]. Through collaborative practice agreements (CPAs), pharmacists can make medication adjustments, order necessary lab tests, and monitor patients' health outcomes under a physician's supervision [25]. This integrated care model ensures that patients receive continuous and coordinated care, addressing all aspects of their health and adherence challenges. By actively participating in multidisciplinary healthcare teams, pharmacists contribute to a holistic approach to chronic disease management, enhancing the overall quality of care and patient outcomes [26, 27].

Evidence of Effectiveness

Studies have shown that community pharmacists' interventions significantly improve medication adherence and clinical outcomes in patients with chronic diseases. Key findings from the literature include:

Improved Clinical Outcomes:

Pharmacist-led interventions are associated with better control of blood pressure, glucose levels, and lipid profiles in patients with hypertension, diabetes, and dyslipidemia, respectively [28].

Reduced Hospitalizations and Emergency Visits: Enhanced adherence leads to fewer hospital admissions and emergency department visits, contributing to overall healthcare cost savings.

Patient Satisfaction and Quality of Life:

Patients receiving pharmacist-led adherence support report higher satisfaction with their care and improved quality of life [29].

Challenges and Barriers

Despite the demonstrated benefits of community pharmacists in enhancing medication adherence for chronic conditions, several challenges and barriers hinder the widespread implementation of these interventions [30]. One significant barrier is the limited reimbursement and funding for pharmacist services, which restricts their ability to provide comprehensive adherence support. Without adequate compensation, pharmacists may not be able to dedicate the necessary time and resources to conduct thorough medication reviews, patient education, and follow-up consultations [31]. Additionally, there is a need for further training and education for pharmacists in areas such as patient counseling, motivational interviewing, and the effective use of adherence tools. Many pharmacists may not have received extensive training in these areas during their formal education, necessitating ongoing professional development to equip them with the skills needed for these expanded roles [32]. Another substantial challenge is the integration of pharmacists into the broader healthcare system. Effective collaboration between pharmacists and other healthcare providers requires changes in healthcare workflows and systems to facilitate communication and teamwork [33]. This includes establishing clear roles, responsibilities, and communication channels within multidisciplinary care teams. Overcoming these barriers is essential for maximizing the potential of community pharmacists in improving medication adherence and managing chronic diseases effectively. Addressing these challenges will require concerted efforts from policymakers, healthcare organizations, and educational institutions to create an environment that supports and enhances the role of pharmacists in chronic disease management [34].

Future Directions to maximize the impact of community pharmacists in managing medication adherence

Policy and Reimbursement Changes: Advocating for policy changes and improved reimbursement for pharmacist services is essential to support their role in adherence management.

Enhanced Training Programs:

Developing training programs focused on adherence support, patient communication, and chronic disease management can equip pharmacists with the necessary skills.

Research and Innovation:

Continued research on innovative adherence interventions and their implementation in diverse healthcare settings will provide valuable insights and evidence for best practices.

Public Awareness Campaigns:

Educating the public about the role of pharmacists in managing chronic diseases and promoting adherence can increase patient engagement and utilization of pharmacist services [35-36].

CONCLUSION

Community pharmacists play a crucial role worldwide by serving as drug experts and providing essential pharmacological advice. They offer limited patient care for minor conditions within their community pharmacies, acting as accessible healthcare providers. In many countries, community pharmacies are key points where individuals can obtain health advice and assistance in managing their disease status with medication, bridging the gap between patients and more extensive healthcare systems. This accessibility and expertise make community pharmacists indispensable in promoting health and well-being within their communities. Chronic diseases are the leading cause of mortality and morbidity in Europe. They significantly impact wages, incomes, labor participation, productivity, and can lead to early retirement, high turnover, and disability. Increasing spending on long-term care across Europe demands more public and private resources. Chronic diseases include cardiovascular disease, diabetes, asthma, and chronic obstructive pulmonary disease (COPD). With improved survival rates and longer illness durations, other diseases such as various cancers, HIV/AIDS, mental illnesses (e.g., depression, schizophrenia, dementia), and disabilities like visual impairment are also considered chronic conditions. Many chronic diseases are associated with an aging population, but lifestyle choices (smoking, sexual behavior, diet, exercise) and genetic predisposition also play roles. Managing chronic diseases requires a coordinated response from multiple health professionals with access to necessary medicines, equipment, and social care. This review examined interprofessional collaboration in chronic disease treatment from five dimensions: partnership, coordination, cooperation, shared decision-making, and therapeutic outcomes.

Type of Interventions by Community Pharmacists

Common interventions included:

Medication Counselling:

• Personalized education sessions about the importance of adherence and how to manage side effects.
• Ensures patients understand the importance of taking their medications as prescribed.
• Educates on the correct dosage and timing.

Medication Therapy Management (MTM):

• Comprehensive reviews of patients' medication regimens to identify and resolve adherence barriers.
• Adherence Monitoring: Use of tools such as electronic medication monitors, pill counts, and patient self-reports.
• Follow-up Calls: Regular phone calls to remind patients about their medication schedules and address any issues.

Effectiveness of Interventions

The majority of studies reported significant improvements in medication adherence rates following pharmacist-led interventions. Adherence improvements ranged from 10% to 40% compared to usual care. Additional outcomes included better clinical indicators (e.g., blood pressure, HbA1c levels), increased patient satisfaction, and reduced healthcare utilization and costs

SUMMARY OF FINDINGS

Community pharmacist-led interventions are effective in improving medication adherence among patients with chronic conditions. The personalized nature of these interventions, combined with regular follow-ups, appears to be key to their success.

Comparison with Previous Reviews

Previous reviews have highlighted the potential role of pharmacists in adherence management, but this review provides more comprehensive and updated evidence on their effectiveness specifically in community settings.

Strengths and Limitations

Strengths:

• Comprehensive search strategy
• Inclusion of diverse study designs and settings

Limitations:

• Heterogeneity in intervention types and adherence measurement methods
• Potential publication bias and variations in study quality
• Implications for Practice
• Community pharmacists should be integrated into multidisciplinary care teams to enhance medication management and adherence support. Training programs and resources should be developed to equip pharmacists with the necessary skills.

FUTURE RESEARCH

Further research should focus on standardizing pharmacist-led interventions and exploring their long-term impact on adherence and clinical outcomes. Conducting Large-scale, randomized controlled trials are needed to validate these findings. The current review highlights the positive outcomes of community pharmacy interventions across five chronic disease categories. However, the primary focus of these interventions has been on patients with existing conditions. It is crucial to encourage community pharmacists to implement proactive interventions aimed at the general or at-risk populations, with a particular emphasis on mental illness and cancer. Additionally, there is a need for further research to determine the relative cost-effectiveness of various interventions and to identify factors that impact the successful implementation of these interventions in community pharmacy settings.

REFERENCE

1. Mohamed HE, Nor Fatin FR, Abdullah AA, Mahmoud EE, Ejaz C: Impact of Pharmacist-Led Interventions on Medication Adherence and Clinical Outcomes in Patients with Hypertension and Hyperlipidemia: A Scoping Review of Published Literature. J Multidiscip Healthc. 2020 Jul 20;13: 635–645.
2. Brown R, Green P. Community pharmacist-led medication therapy management and adherence improvement. American Journal of Health-System Pharmacy. 2016;73(8): 531-542.
3. World Health Organization. Chronic disease. Available from: Accessed 09 Feb 2011.
4. World Health Organization. Global strategy for health for all by the year 2000.
5. Bosworth HB, Olsen MK, Grubber JM, Neary A, Orr M, Powers BJ, Oddone EZ. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med. 2009;151(10):687–695.
6. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Jimenez-Silva J, Speight N, Lehman R, Thabane L, Haynes RB. Interventions for enhancing medication adherence. Cochrane Database Syst Rev.2014:11.
7. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V.  Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018; 8(1).
8. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011; 86(4):304–314
9. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169(19):1748–1755.
10. Ali M, Schifano F, Robinson P, Phillips G, Doherty L, Melnick P, Hughes D. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012; 29(9):e333.
11. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009; 43(5):882–889.
12. World Health Organization. Chronic disease and health promotion. Available from: Accessed 17 Sep 2012.
13. Fikri-Benbrahim N, Faus MJ, Martinez-Martinez F, Sabater-Hernandez D. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm. 2013; 9(6):797–805.
14. Kooij MJ, Heerdink ER, van Dijk L, Gebel C, de Gier JJ, Bouvy ML. Effects of a medication adherence program in community pharmacies on diabetes patients. Pharm World Sci. 2005; 27(3):136–142.
15. Saini B, Filipovska J, Bosnic-Anticevich S, Taylor S, Krass I, Armour C, Smith L. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health. 2008; 16(2):100–108.
16. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004; 44(2):161–167.
17. Law AV, Okamoto MP, Chang PS. Prevalence and types of disease management programs in community pharmacies in California. J Managed Care Pharm. 2005; 11(6):505–512.
18. Armour BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010; 23(3):250–264.
19. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003; 25(2):144–153.
20. Department of Health and Aging. Chronic disease. Available from: Accessed 23 Feb 2011.
21. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2. 2008.
22. Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014; 33(8):1444–1452.
23. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Clark D, Wu J, Weinberger M. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007; 146(10):714–725.
24. Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Graff Zivin J, Abraham I, Palmer J, Martin JR, Kramer SS, Wunz T. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010; 48(10):923–933.
25. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487–497.
26. Basak SC, Van Mil JW, Sathyanarayana D. The changing roles of pharmacists in community pharmacies: perception of reality in India. Pharm World Sci.2009; 31(6):612–618.
27. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007; 41(11):1770–1781.
28. Benavides, S., & Hernandez, J. Improving medication adherence in patients with chronic diseases: The role of community pharmacists. Journal of Pharmacy Practice. 2016; 29(4), 482-490.
29. Carter, B. L., & Ardery, G. Pharmacist intervention in blood pressure control: The Iowa experience. Journal of Clinical Hypertension. 2009; 11(6), 315-319.
30. Fera, T., & Ellis, W. M. Diabetes Ten City Challenge: Final economic and clinical results. Journal of the American Pharmacists Association. 2009; 49(3), 383-391.
31. Machado, M., & Einarson, T. R. Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Annals of Pharmacotherapy. 2007; 41(10), 1569-1582.
32. McLean, W., & Waller, R. (2003). The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Canadian Respiratory Journal. 2003; 10(4), 195-202.
33. Miller, G. E., & Glover, J. J. Improving adherence to treatment in hypertensive patients through medication therapy management. Journal of Managed Care & Specialty Pharmacy. 2012; 18(8), 675-685.
34. Odegard, P. S., & Gray, S. L. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educator. 2008; 34(4), 692-697.
35. Hughes, C. M., & McCann, S. Perceived interprofessional barriers between community pharmacists and general practitioners: A qualitative assessment. British Journal of General Practice. 2003; 53(493), 600-606.
36. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann  Intern Med. 2012; 157(11):785–795.